Xijie Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xijie Zhang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Mao Huang
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2 shared publications - Mingshun Zhang
Jiangsu Province Engineering Research Center of Antibody Drug, NHC Key Laboratory of Antibody Technique, Department of Immunology, Nanjing Medical University, Nanjing, China
2 shared publications - Ningfei Ji
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2 shared publications - Qi Yuan
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2 shared publications - Tingting Xu
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2 shared publications - Xinyu Jia
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2 shared publications
Latest Publications
- Open Access
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (4) , 422-433
LincR-PPP2R5C Deficiency Alleviates Airway Remodeling by Inhibiting Epithelial-Mesenchymal Transition Through the PP2A/TGF-β1 Signaling Pathway in Chronic Experimental Allergic Asthma
Yuan Q, et al. Allergy Asthma Immunol Res. 2024 Jul;16(4):422-433. https://doi.org/10.4168/aair.2024.16.4.422
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (4) , 422-433
Open AccessLincR-PPP2R5C Deficiency Alleviates Airway Remodeling by Inhibiting Epithelial-Mesenchymal Transition Through the PP2A/TGF-β1 Signaling Pathway in Chronic Experimental Allergic Asthma
Yuan Q, et al. Allergy Asthma Immunol Res. 2024 Jul;16(4):422-433. https://doi.org/10.4168/aair.2024.16.4.422
- Open Access
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (1) , 71-90
LincR-PPP2R5C Promotes Th2 Cell Differentiation Through PPP2R5C/PP2A by Forming an RNA–DNA Triplex in Allergic Asthma
Ji N, et al. Allergy Asthma Immunol Res. 2024 Jan;16(1):71-90. https://doi.org/10.4168/aair.2024.16.1.71
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (1) , 71-90
Open AccessLincR-PPP2R5C Promotes Th2 Cell Differentiation Through PPP2R5C/PP2A by Forming an RNA–DNA Triplex in Allergic Asthma
Ji N, et al. Allergy Asthma Immunol Res. 2024 Jan;16(1):71-90. https://doi.org/10.4168/aair.2024.16.1.71
- Open Access
- 15 July 2014
- Published by Wolters Kluwer Health in Transplantation
- Vol. 98, 284-285
A New Tolerogenic Strategy to Attenuate Acute GVHD By a Neoteric MyD88 Inhibitor in Mice.
- 15 July 2014
- Published by Wolters Kluwer Health in Transplantation
- Vol. 98, 284-285
Open AccessA New Tolerogenic Strategy to Attenuate Acute GVHD By a Neoteric MyD88 Inhibitor in Mice.